Malaria,Falciparum Clinical Trials

9 recruitingLast updated: June 17, 2026

There are 9 actively recruiting malaria,falciparum clinical trials across 11 countries. Studies span Phase 1, Not Applicable, Phase 2, Phase 3, Phase 4. Top locations include Siglé, Boulkiemdé Province, Burkina Faso, Antananarivo, Madagascar, Bousse, Burkina Faso, Burkina Faso. Updated daily from ClinicalTrials.gov.


Malaria,Falciparum Trials at a Glance

9 actively recruiting trials for malaria,falciparum are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Phase 1 with 5 trials, with the heaviest enrollment activity in Siglé, Antananarivo, and Bousse. Lead sponsors running malaria,falciparum studies include University of Oxford, London School of Hygiene and Tropical Medicine, and GlaxoSmithKline.

Browse malaria,falciparum trials by phase

Treatments under study

About Malaria,Falciparum Clinical Trials

Looking for clinical trials for Malaria,Falciparum? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Malaria,Falciparum trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Malaria,Falciparum clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 1

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants

Malaria,Falciparum
Medicines for Malaria Venture72 enrolled1 locationNCT07011511
Recruiting
Phase 1

Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults

Malaria,Falciparum
Sanaria Inc.58 enrolled1 locationNCT06862453
Recruiting
Phase 1

A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

Malaria,Falciparum
GlaxoSmithKline156 enrolled1 locationNCT06171113
Recruiting
Phase 3

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

Malaria,FalciparumMalaria, VivaxPlasmodium Vivax+1 more
London School of Hygiene and Tropical Medicine19,200 enrolled2 locationsNCT06923592
Recruiting
Phase 1

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)

Malaria,Falciparum
University of Oxford56 enrolled1 locationNCT06958198
Recruiting
Not Applicable

Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana

Malaria infectionMalaria,FalciparumMalaria Asymptomatic Parasitaemia+1 more
Noguchi Memorial Institute for Medical Research9,000 enrolled1 locationNCT07389057
Recruiting
Phase 4

Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics

Low birthweightPregnancyPreterm Birth+6 more
Duke University2,500 enrolled2 locationsNCT05757167
Recruiting

An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine

MoralityMalaria,Falciparum
Serum Institute of India Pvt. Ltd.2,308 enrolled5 locationsNCT07009847
Recruiting
Phase 1Phase 2

A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

Malaria,Falciparum
University of Oxford480 enrolled1 locationNCT05790889